Evidence map›Paper›PMID 38224028›Full record

ArticleIranian biomedical journal2024

Lessons from COVID-19 Pandemic: A Successful Policy and Practice by Pasteur Institute of Iran.

Mona Sadat Larijani, Alireza Biglari, Rahim Sorouri, Mostafa Salehi-Vaziri, Delaram Doroud, Keyhan Azadmanesh, Fatemeh Fotouhi, Ehsan Mostafavi, Amitis Ramezani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian biomedical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mona Sadat LarijaniClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Alireza BiglariSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Rahim SorouriIPI Directorate, Pasteur Institute of Iran, Tehran, Iran.
Mostafa Salehi-VaziriCOVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran.
Delaram DoroudQuality Control Department, Production and research Complex, Pasteur Institute of Iran, Tehran, Iran.
Keyhan AzadmaneshDepartment of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.
Fatemeh FotouhiDepartment of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran.
Ehsan MostafaviDepartment of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
Amitis RamezaniClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aims to provide an insight to the comprehensive efforts of Pasteur Institute of Iran (PII) regarding COVID-19 management, research, achievements, and vaccine production, though there are many challenges. The relevant literature review was investigated through national and international database and also reports from the related research departments. Six strategies were taken by PII to manage the pandemic of COVID-19. While this pandemic has been hopefully controlled, SARS-CoV-2 could still be a potential threat. Therefore, COVID-19 data management and updated studies, as well as long-term safety and efficacy of the SARS-CoV-2 vaccines are still on the agenda.

Indexed as

COVID-19Viral VaccinesCOVID-19 VaccinesHumansIranPandemicsPolicySARS-CoV-2COVID-19 VaccinesViral VaccinesCOVID-19PandemicsVaccines

Identifiers

PMID38224028
PMCPMC10994636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.